CUREosity GmbH, the innovative MedTech company from Düsseldorf, announces the successful conclusion of a growth financing round. A total of 3.8 million euros was committed by existing and new investors in the completed growth financing round.

CUREosity GmbH announces today's release of CUREO4, the latest version of our certified and well-established virtual reality therapy software.

CUREosity GmbH, Techniker Krankenkasse (TK) and Ambulanticum GmbH announce the start of a joint pilot project on February 1, 2024.

New research results on the effectiveness of VR therapy with CUREO in the treatment of severe arm paresis in stroke patients Published in December 2023 in the journal Frontiers in Neurology.

Caesar van Heyningen, Chief Executive Officer (CEO) of CUREosity GmbH, is list maker of Forbes’ "30 under 30" list this year.

We are pleased to announce that CUREosity is now certified according to the ISO 13485 standards.

CUREosity GmbH announces a change in its management team: Caesar van Heyningen will take on the role of CEO (Chief Executive Officer) as of July 1, 2023.